AllianceBernstein’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

AllianceBernstein’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-95,000	Closed	-$3.1M	–	3169
2018 Q1	$3.1M	Buy	+95,000	New	+$4.17M	﹤0.01%	1519

AllianceBernstein's PTLA Position: Q3 2020 in Review

AllianceBernstein sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 574,974 shares — an estimated $10.3M sold.

AllianceBernstein first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $20.4M in Q4 2013. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

AllianceBernstein reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
AllianceBernstein sold 574,974 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.3M.
AllianceBernstein first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
AllianceBernstein's Portola Pharmaceuticals, Inc. position peaked at $20.4M in Q4 2013.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on AllianceBernstein's 13F filing for Q3 2020, filed 12 Nov 2020.